Inhibition of the tubular epithelial-to-mesenchymal transition in vivo and in vitro by the Uremic Clearance Granule

Chinese Journal of Integrative Medicine

Volumn 19, Issue 12, 2013, Pages 918-926

  Lu, Zhao Yu ^a,b   Liu, Shu Wen ^a   Xie, Yuan Sheng ^a   Cui, Shao Yuan ^a   Liu, Xu Sheng ^b   Geng, Wen Jia ^a,b   Hu, Xiao ^a   Ji, Jia Yao ^a   Chen, Xiang Mei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

Author keywords

epithelial to mesenchymal transition; tubulointerstitial fibrosis; Uremic Clearance Granule

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; CHINESE DRUG; HERBACEOUS AGENT; PLANT EXTRACT; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UREMIC CLEARANCE GRANULE; URINARY TRACT AGENT; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; INFANT; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; KIDNEY TUBULE EPITHELIUM; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; URETER OBSTRUCTION; WESTERN BLOTTING;

ANIMALS; BLOOD; BLOTTING, WESTERN; CELL LINE; CULTURE MEDIA; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; KIDNEY TUBULES; MALE; RATS; RATS, SPRAGUE-DAWLEY; UREMIA;

EID: 84890933873     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-013-1654-9     Document Type: Article

References (29)

1. Bohle A, Muller GA, Wehrmann M, Xiao JC. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies and chronic interstitial nephritides. Kidney Int 1996;54:2-9.
2. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 2004;43:9-17.
3. Zeisberg M, Kaluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 2004;82:175-181.
4. Huan HD, Zhang JH, Zheng SR, Meng WW, Zhang JL. Dilingdan Decoction prevents renal interstitial fibrosis in a rat model of unilateral ureteral obstruction. J Chin Integr Med (Chin) 2008;6:493-497.
5. Hu Q, Noor M, Wong YF, Hylands PJ, Simmonds MS, Xu Q, et al. In vitro anti-fibrotic activities of herbal compounds and herbs. Nephrol Dial Transplant 2009;24:3033-3041.
6. Wu HL, Lin HC, Ruan XL. Observation of the curative efficiency of uremic clearance granules in 118 patients with chronic renal failure. Chin J Integr Tradit West Nephrol (Chin) 2004;5:21-24.
7. Wang L, Gui BS, Fu RG, Ou Y. Influence of Uremic Clearance Granule on blood fat in chronic renal insufficiency patients. Modern J Integr Tradit Chin West Med (Chin) 2009;18:1579-1580.
8. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110:341-350.
9. Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002;13:96-107.
10. Iwama H, Amagaya S, Ogihara Y. A Japanese and Chinese traditional herbal medicinal mixture, on the mitogenic activity of lipopolysaccharide: a new pharmacological testing method. J Ethnopharmacol 1987;21:45-53.
11. Gao D, Wu LY, Jiao YH, Chen WY, Chen Y, Kaptchuk TJ, et al. The effect of Xuefu Zhuyu Decoction on in vitro endothelial progenitor cell tube formation. Chin J Integr Med 2010;16:50-53.
12. Hevalier RL, Thornhill BA, Wolstenholme JT, Kim A. Unilateral ureteral obstruction in early development alters renal growth: dependence on the duration of obstruction. J Urol 1999;161:309-313.
13. Zhou QG, Zheng FL, Hou FF. Inhibition of tubulointerstitial fibrosis by pentoxifylline is associated with improvement of vascular endothelial growth factor expression. Acta Pharmacol Sin 2009;30:98-106.
14. Zager RA, Johnson AC, Hanson SY. Renal tubular triglyercide accumulation following endotoxic, toxic, and ischemic injury. Kidney Int 2005; 67:111-121.
15. Copeland JW, Beaumont BW, Merrilees MJ, Pilmore HL. Epithelial-to- mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation 2007;83:809-814.
16. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, et al. Connective tissue growth factor plays an important role in advanced glycation end productinduced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006;17:2484-2494.
17. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004;15:1-12.
18. Burns WC, Kantharidis P, Thomas MC. The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs 2007;185:222-231.
19. Grande MT, Lopez-Novoa JM. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol 2009;5:319-328.
20. Nie J, Wu Q, Liu W, Zhu F, Qiu F, Zhou Q, et al. Ectopic expression of Ligand-of-Numb protein X promoted TGFbeta induced epithelial to mesenchymal transition of proximal tubular epithelial cells. Biochim Biophys Acta 2009;1792:122-131.
21. Chen YX, Li Y, Wang WM, Zhang W, Chen XN, Xie YY, et al. Phosphoproteomic study of human tubular epithelial cell in response to transforming growth factor-beta-1-induced epithelial-to-mesenchymal transition. Am J Nephrol 2010;31:24-35.
22. Jin H, Sakaida I, Tsuchiya M, Okita K. Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Life Sci 2005;76:2805-2816.
23. Gui SY, Wei W, Wang H, Wu L, Sun WY, Chen WB. Effects and mechanisms of crude astragalosides fraction on liver fibrosis in rats. J Ethnopharmacol 2006;103:154-159.
24. Wang JJ, Li J, Shi L, Lv XW, Cheng WM, Chen YY. Preventive effects of a fractioned polysaccharide from a traditional Chinese herbal medical formula (Yu Ping Feng San) on carbon tetrachloride-induced hepatic fibrosis. J Pharm Pharmacol 2010;62:935-942.
25. Li X, Shen J, Zhong Z, Wen H, Luo Q, Wei W. Paeoniflorin: a monomer from traditional Chinese medical herb ameliorates Schistosoma japonicum egg-induced hepatic fibrosis in mice. J Parasitol 2009;95:1520-1524.
26. Yao G, Xu L, Wu X, Xu L, Yang J, Chen H. Preventive effects of salvianolic acid B on transforming growth factorbeta1-induced epithelial-to-mesenchymal transition of human kidney cells. Biol Pharm Bull 2009;32:882-886.
27. Wang QL, Tao YY, Yuan JL, Shen L, Liu CH. Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro. BMC Cell Biol 2010;5:11-31.
28. Guarino M, Tosoni A, Nebuloni M. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Hum Pathol 2009;40:1365-1376.
29. Wang XJ, Sun WJ, Sun H, Lv H, Wu Z, Wang P, et al. Analysis of the constituents in the rat plasma after oral administration of Yin Chen Hao Tang by UPLC/Q-TOF-MS/MS. J Pharmaceut Biomed 2008;46:477-490.